ADJUNCTIVE USE OF ESOMEPRAZOLE IN THE TREATMENT OF PRE-ECLAMPSIA: A CASE REPORT AND LITERATURE REVIEW
Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 6
Abstract
Faced with the absence of suitable assays and/or kits for predictive biomarkers, medical practitioners in poor resource settings may be emasculated by the unrelenting upwards prevalence of and uncertain forecast associated with the pre-eclampsia/eclampsia and fetal growth restriction disease spectrum. Low-birth weight and pre-eclampsia due to placental malaria, multiple pregnancy and malnutrition may be reactive oxygen species - and anti-angiogenic factors – dependent. Adjunctive esomeprazole promises to be a treatment regimen that may lead to cure for it has been found to attenuate the known pathophysiologic mechanisms responsible for pre-eclampsia and IUGR which may be imbalance between pro-angiogenic and anti-angiogenic factors. The proton pump inhibitor, esomeprazole, decreases the excessive secretion of the anti-angiogenic factors soluble fms-like tyrosine kinase-I (sFlt-I) and soluble endoglin from the placenta responsible for the hypertension, endothelial dysfunction, multiorgan injury and foetal growth restriction in preeclampsia. sFlt-I binds the pro-angiogenic placenta growth factor (PIGF) and vascular endothelial growth factor (VEGF), the circulating free forms of which are low in preeclampsia. Case report is of a 32-year old Nigerian housewife who showed significant reduction in blood pressure, proteinuria and pedal oedema with esomeprazole add-on to a regimen of methyl- dopa for severe preeclampsia. The combination significantly (P < 0.05) decreased the selected indices of uteroplacental insufficiency of proteinuria, serum uric acid levels, blood pressure, umbilical resistance index, pulsatility index and systolic/diastolic ratio. This report corroborates the accumulating pre-clinical data on the safety and efficacy of esomeprazole in the treatment of preeclampsia, a precursor of eclampsia.
Authors and Affiliations
Dr. S. E. Oriaifo
Keywords
Related Articles
- EP ID EP618252
- DOI -
- Views 163
- Downloads 0
COLLATERAL EFFECTS IN WOMEN WITH BREAST CANCER PRESENTED BY PROTOCOL ANTHRACYCLINE, CYCLOPHOSPHAMIDE AND TAXANE (ACT) ASSOCIATED TO LIFE´S STYLE AND EMOTIONAL STATE: LITERATURE´S REVIEW
Breast cancer is the most common and worldwide incident type of cancer among women. From distrust to aftercare, deleterious effects impacts both psychological and physical health influencing directly in patient´s life qu...
THE PHARMACIST ROLE IN PATIENTS’ QUALITY OF LIFE
Background: In the recent decades the quality-of-life studies have revealed that the assessed data can produce vital information about patients’ interaction with illness and their response to treatment. The aim of this r...
IN VITRO ANTI-MICROBIAL AND CYTOTOXIC ACTIVITY ANALYSIS OF CISSUS ADNATA IN DIFFERENT FRACTIONS
This study provides a scientific basis for the use of Cissus adnata in traditional medicine. The whole plant was extracted using methanol and different partitionates were obtained using different organic solvents, like,...
ANTIHYPERGLYCEMIC EFFECT OF METHANOL EXTRACT OF MUSA SAPIENTUM FRUIT SKINS IN GLUCOSE-CHALLENGED MICE
Background. As part of our ongoing anti-diabetic project to identify local plant species and plant parts which can lower blood glucose levels, the objective of the present study was to determine the antihyperglycemic eff...
A REVIEW ON TRANSUNGUAL DRUG DELIVARY SYSTEM
The nail disorders are mainly due to fungal infection. When the drug is given through oral or systemic route, the potency of drugs gets decreased at the site of action. To avoid this loss of drug potency topical route of...